Thrombosis in children

Christine A Macartney1, Anthony K C Chan

  • 1Department of Paediatric Haematology, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland, United Kingdom. christine.macartney@belfasttrust.hscni.net

Insights

Pediatric thrombosis is rising, but treatment guidelines lack specific pediatric data. This review examines causes, diagnosis, and management of thrombosis in children over one year old.

Area of Science:

  • Pediatric Hematology
  • Vascular Biology
  • Clinical Pediatrics

Background:

  • Thrombosis incidence in children is increasing, driven by greater awareness and medical advancements.
  • Managing pediatric thrombosis presents unique challenges due to developmental differences in the hemostatic system compared to adults.
  • Current treatment guidelines for pediatric thrombosis are often derived from adult data, potentially overlooking specific pediatric needs.

Purpose of the Study:

  • To review the etiology, diagnosis, and management of thrombosis in children over one year of age.
  • To highlight the complexities and current gaps in treating pediatric thrombosis.
  • To synthesize available data for this specific pediatric population.

Main Methods:

  • Literature review focusing on children over 1 year of age and adolescents.
  • Analysis of existing data on pediatric thrombosis etiology and diagnosis.
  • Examination of current and emerging management strategies and associated complications.

Main Results:

  • A growing body of research is becoming available for pediatric thrombosis.
  • Existing guidelines may not fully address the distinct hemostatic profiles of children.
  • Further prospective, controlled trials are needed for evidence-based pediatric thrombosis management.

Conclusions:

  • Thrombosis in children over one year old requires tailored approaches due to unique hemostatic differences.
  • Addressing the lack of pediatric-specific research is crucial for optimizing treatment outcomes.
  • This review provides a comprehensive overview to guide future research and clinical practice in pediatric thrombosis.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...